1. Glass PSA, Hardman D, Kamiyama Y, Quill TJ, Marton G, Donn KH, Grosse CM, Hermann D. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: Remifentanil (GI87084B). Anesth Analg. 1993;77:1031–40.
2. Marson L, Kiritsy-Roy JA, Van Loon GR. μ-opioid peptide modulation of cardiovascular and sympathoadrenal responses to stress. Am J Physiol. 1989;257:R901–8.
3. Pfeiffer A, Feuerstein G, Zerbe RL, Faden AI, Kopin IJ. μ-receptors mediate opioid cardiovascular effects at anterior hypothalamic sites through sympatho-adrenomedullary and parasympathetic pathways. Endocrinology. 1983;113:929–38.
4. Szilagyi JE. Opioid modulation of baroreceptor reflex sensitivity in dogs. Am J Physiol. 1987;252:H733–7.
5. Elliott P, O’Hare R, Bill KM, Phillips AS, Gibson FM, Mirakhur K. Severe cardiovascular depression with remifentanil. Anesth Analg. 2000;91:58–61.